Cardiff Oncology (CRDF) Change in Acquisitions & Divestments (2016 - 2025)
Cardiff Oncology (CRDF) has disclosed Change in Acquisitions & Divestments for 8 consecutive years, with $69.9 million as the latest value for Q4 2025.
- Quarterly Change in Acquisitions & Divestments changed N/A to $69.9 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $71.1 million through Dec 2025, up 592.75% year-over-year, with the annual reading at $71.1 million for FY2025, 592.75% up from the prior year.
- Change in Acquisitions & Divestments hit $69.9 million in Q4 2025 for Cardiff Oncology, up from -$33.8 million in the prior quarter.
- In the past five years, Change in Acquisitions & Divestments ranged from a high of $76.4 million in Q4 2023 to a low of -$58.1 million in Q3 2023.
- Historically, Change in Acquisitions & Divestments has averaged $13.2 million across 5 years, with a median of $13.8 million in 2025.
- Biggest five-year swings in Change in Acquisitions & Divestments: skyrocketed 2746.01% in 2023 and later plummeted 1408.21% in 2025.
- Year by year, Change in Acquisitions & Divestments stood at $19.4 million in 2021, then tumbled by 86.18% to $2.7 million in 2022, then surged by 2746.01% to $76.4 million in 2023, then tumbled by 102.93% to -$2.2 million in 2024, then skyrocketed by 3219.42% to $69.9 million in 2025.
- Business Quant data shows Change in Acquisitions & Divestments for CRDF at $69.9 million in Q4 2025, -$33.8 million in Q3 2025, and $13.8 million in Q2 2025.